Follow the people · Insider
Paul J. Sekhri
Paul J. Sekhri files insider transactions with the SEC as a director of Veeva Systems (VEEV). We hold 1 disclosed purchase or sale filed since 9 November 2007, 1 of them in the last 90 days.
- Files forVEEV
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure3 September 2026
Positions held
10 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 September 2014 — 1 September 2026Director · Veeva Systems (VEEV)131 Form 4 lines · source: SEC Form 4
- Filed 30 July 2026 — 3 August 2026Director · Apnimed (APMD)9 Form 4 lines · source: SEC Form 4
- Filed 27 February 2024 — 17 February 2026Pres, CEO and Exec Chairperson · vTv Therapeutics (VTVT)7 Form 4 lines · source: SEC Form 4
- Filed 24 May 2022 — 2 December 2024Director · Longboard Pharmaceuticals (LBPH)7 Form 4 lines · source: SEC Form 4
- Filed 19 May 2022 — 19 May 2022Director · Axcella Health (AXLA)1 Form 4 line · source: SEC Form 4
- Filed 2 October 2020 — 28 July 2021Director · BiomX (PHGE)4 Form 4 lines · source: SEC Form 4
- Filed 2 January 2018 — 2 January 2020Director · Alpine Immune Sciences (ALPN)3 Form 4 lines · source: SEC Form 4
- Filed 22 September 2015 — 9 December 2016Director · Enumeral Biomedical Holdings (ENUM)5 Form 4 lines · source: SEC Form 4
- Filed 12 September 2016 — 12 September 2016Director · Nivalis Therapeutics (NVLS)1 Form 4 line · source: SEC Form 4
- Filed 7 November 2007 — 30 April 2010Director · ARYx Therapeutics (ARYX)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 460 shares of Veeva SystemsSEC Form 43 September 2026Class A Common Stock · traded 1 September 2026 · filed 3 September 2026
- exercised options over 460 shares of Veeva Systems (a derivative holding)SEC Form 43 September 2026Restricted Stock Units · traded 1 September 2026 · filed 3 September 2026
- ▲ bought on the open market 12,500 shares of ApnimedSEC Form 43 August 2026Common Stock · traded 3 August 2026 · filed 3 August 2026
- returned to the issuer 169,468 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 169,468 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 155,558 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 30 July 2026 · filed 3 August 2026
- returned to the issuer 155,558 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 155,558 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 22,238 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 30 July 2026 · filed 3 August 2026
- returned to the issuer 22,238 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 22,238 shares of Apnimed (a derivative holding)SEC Form 43 August 2026Stock Option (Right to Buy) · traded 3 August 2026 · filed 3 August 2026
- was granted 1,841 shares of Veeva Systems (a derivative holding)SEC Form 422 June 2026Restricted Stock Units · traded 17 June 2026 · filed 22 June 2026
- exercised options over 253 shares of Veeva SystemsSEC Form 43 June 2026Class A Common Stock · traded 1 June 2026 · filed 3 June 2026
- exercised options over 253 shares of Veeva Systems (a derivative holding)SEC Form 43 June 2026Restricted Stock Units · traded 1 June 2026 · filed 3 June 2026
- exercised options over 253 shares of Veeva SystemsSEC Form 43 March 2026Class A Common Stock · traded 1 March 2026 · filed 3 March 2026
- exercised options over 253 shares of Veeva Systems (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 1 March 2026 · filed 3 March 2026
- exercised options over 253 shares of Veeva Systems (a derivative holding)SEC Form 43 March 2026Restricted Stock Units · traded 1 March 2026 · filed 3 March 2026
- exercised options over 253 shares of Veeva SystemsSEC Form 43 March 2026Class A Common Stock · traded 1 March 2026 · filed 3 March 2026
- was granted 140,000 shares of vTv Therapeutics (a derivative holding)SEC Form 418 February 2026Class A Common Stock · traded 17 February 2026 · filed 18 February 2026
- was granted 140,000 shares of vTv Therapeutics (a derivative holding)SEC Form 418 February 2026Class A Common Stock · traded 17 February 2026 · filed 18 February 2026
- exercised options over 254 shares of Veeva Systems (a derivative holding)SEC Form 43 December 2025Restricted Stock Units · traded 1 December 2025 · filed 3 December 2025
- exercised options over 254 shares of Veeva SystemsSEC Form 43 December 2025Class A Common Stock · traded 1 December 2025 · filed 3 December 2025
- gave away 2,491 shares of Veeva SystemsSEC Form 43 December 2025Class A Common Stock · traded 2 December 2025 · filed 3 December 2025
- exercised options over 253 shares of Veeva Systems (a derivative holding)SEC Form 43 September 2025Restricted Stock Units · traded 1 September 2025 · filed 3 September 2025
- exercised options over 253 shares of Veeva SystemsSEC Form 43 September 2025Class A Common Stock · traded 1 September 2025 · filed 3 September 2025
- was granted 1,013 shares of Veeva Systems (a derivative holding)SEC Form 420 June 2025Restricted Stock Units · traded 18 June 2025 · filed 20 June 2025
- exercised options over 329 shares of Veeva Systems (a derivative holding)SEC Form 42 June 2025Restricted Stock Units · traded 1 June 2025 · filed 2 June 2025
- exercised options over 329 shares of Veeva SystemsSEC Form 42 June 2025Class A Common Stock · traded 1 June 2025 · filed 2 June 2025
- was granted 108,000 shares of vTv Therapeutics (a derivative holding)SEC Form 47 March 2025Employee stock option (right to buy) · traded 1 March 2025 · filed 7 March 2025
- exercised options over 328 shares of Veeva Systems (a derivative holding)SEC Form 43 March 2025Restricted Stock Units · traded 1 March 2025 · filed 3 March 2025
- exercised options over 328 shares of Veeva SystemsSEC Form 43 March 2025Class A Common Stock · traded 1 March 2025 · filed 3 March 2025
- returned to the issuer 25,461 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 42 December 2024Employee Stock Option (right to buy) · traded 2 December 2024 · filed 2 December 2024
- returned to the issuer 12,367 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 42 December 2024Employee Stock Option (right to buy) · traded 2 December 2024 · filed 2 December 2024
- returned to the issuer 12,500 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 42 December 2024Employee Stock Option (right to buy) · traded 2 December 2024 · filed 2 December 2024
- returned to the issuer 22,500 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 42 December 2024Employee Stock Option (right to buy) · traded 2 December 2024 · filed 2 December 2024
- exercised options over 329 shares of Veeva Systems (a derivative holding)SEC Form 42 December 2024Restricted Stock Units · traded 1 December 2024 · filed 2 December 2024
- exercised options over 329 shares of Veeva SystemsSEC Form 42 December 2024Class A Common Stock · traded 1 December 2024 · filed 2 December 2024
- ▲ bought on the open market 1,378 shares of vTv TherapeuticsSEC Form 419 November 2024Class A Common Stock · traded 15 November 2024 · filed 19 November 2024
- ▲ bought on the open market 1,778 shares of vTv TherapeuticsSEC Form 419 November 2024Class A Common Stock · traded 15 November 2024 · filed 19 November 2024
- ▲ bought on the open market 1,844 shares of vTv TherapeuticsSEC Form 419 November 2024Class A Common Stock · traded 18 November 2024 · filed 19 November 2024
- exercised options over 329 shares of Veeva Systems (a derivative holding)SEC Form 43 September 2024Restricted Stock Units · traded 1 September 2024 · filed 3 September 2024
- exercised options over 329 shares of Veeva SystemsSEC Form 43 September 2024Class A Common Stock · traded 1 September 2024 · filed 3 September 2024
- was granted 1,315 shares of Veeva Systems (a derivative holding)SEC Form 420 June 2024Restricted Stock Units · traded 19 June 2024 · filed 20 June 2024
- was granted 89,212 shares of vTv Therapeutics (a derivative holding)SEC Form 413 June 2024Employee stock option (right to buy) · traded 27 February 2024 · filed 13 June 2024
- exercised options over 290 shares of Veeva Systems (a derivative holding)SEC Form 43 June 2024Restricted Stock Units · traded 1 June 2024 · filed 3 June 2024
- exercised options over 290 shares of Veeva SystemsSEC Form 43 June 2024Class A Common Stock · traded 1 June 2024 · filed 3 June 2024
- was granted 22,500 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 424 May 2024Stock Option (Right to Buy) · traded 23 May 2024 · filed 24 May 2024
- exercised options over 290 shares of Veeva Systems (a derivative holding)SEC Form 45 March 2024Restricted Stock Units · traded 1 March 2024 · filed 5 March 2024
- exercised options over 290 shares of Veeva SystemsSEC Form 45 March 2024Class A Common Stock · traded 1 March 2024 · filed 5 March 2024
- exercised options over 290 shares of Veeva Systems (a derivative holding)SEC Form 41 December 2023Restricted Stock Units · traded 1 December 2023 · filed 1 December 2023
- exercised options over 290 shares of Veeva SystemsSEC Form 41 December 2023Class A Common Stock · traded 1 December 2023 · filed 1 December 2023
- ▼ sold on the open market 2,500 shares of Veeva SystemsSEC Form 412 September 2023Class A Common Stock · traded 11 September 2023 · filed 12 September 2023
- exercised options over 290 shares of Veeva Systems (a derivative holding)SEC Form 45 September 2023Restricted Stock Units · traded 1 September 2023 · filed 5 September 2023
- exercised options over 290 shares of Veeva SystemsSEC Form 45 September 2023Class A Common Stock · traded 1 September 2023 · filed 5 September 2023
- was granted 1,160 shares of Veeva Systems (a derivative holding)SEC Form 423 June 2023Restricted Stock Units · traded 21 June 2023 · filed 23 June 2023
- exercised options over 313 shares of Veeva Systems (a derivative holding)SEC Form 45 June 2023Restricted Stock Units · traded 1 June 2023 · filed 5 June 2023
- exercised options over 313 shares of Veeva SystemsSEC Form 45 June 2023Class A Common Stock · traded 1 June 2023 · filed 5 June 2023
- was granted 12,500 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 426 May 2023Stock Option (Right to Buy) · traded 25 May 2023 · filed 26 May 2023
- ▼ sold on the open market 2,540 shares of Veeva SystemsSEC Form 46 March 2023Class A Common Stock · traded 3 March 2023 · filed 6 March 2023
- ▼ sold on the open market 118 shares of Veeva SystemsSEC Form 46 March 2023Class A Common Stock · traded 3 March 2023 · filed 6 March 2023
- exercised options over 313 shares of Veeva Systems (a derivative holding)SEC Form 43 March 2023Restricted Stock Units · traded 1 March 2023 · filed 3 March 2023
- exercised options over 313 shares of Veeva SystemsSEC Form 43 March 2023Class A Common Stock · traded 1 March 2023 · filed 3 March 2023
- gave away 702 shares of Veeva SystemsSEC Form 420 December 2022Class A Common Stock · traded 16 December 2022 · filed 20 December 2022
- exercised options over 313 shares of Veeva Systems (a derivative holding)SEC Form 45 December 2022Restricted Stock Units · traded 1 December 2022 · filed 5 December 2022
- exercised options over 313 shares of Veeva SystemsSEC Form 45 December 2022Class A Common Stock · traded 1 December 2022 · filed 5 December 2022
- exercised options over 313 shares of Veeva Systems (a derivative holding)SEC Form 46 September 2022Restricted Stock Units · traded 1 September 2022 · filed 6 September 2022
- exercised options over 313 shares of Veeva SystemsSEC Form 46 September 2022Class A Common Stock · traded 1 September 2022 · filed 6 September 2022
- was granted 1,252 shares of Veeva Systems (a derivative holding)SEC Form 413 June 2022Restricted Stock Units · traded 9 June 2022 · filed 13 June 2022
- exercised options over 189 shares of Veeva Systems (a derivative holding)SEC Form 42 June 2022Restricted Stock Units · traded 1 June 2022 · filed 2 June 2022
- exercised options over 189 shares of Veeva SystemsSEC Form 42 June 2022Class A Common Stock · traded 1 June 2022 · filed 2 June 2022
- was granted 12,367 shares of Longboard Pharmaceuticals (a derivative holding)SEC Form 431 May 2022Stock Option (Right to Buy) · traded 24 May 2022 · filed 31 May 2022
- was granted 40,000 shares of Axcella Health (a derivative holding)SEC Form 425 May 2022Stock Option (Right to Buy) · traded 19 May 2022 · filed 25 May 2022
- ▼ sold on the open market 11,000 shares of Veeva SystemsSEC Form 41 April 2022Class A Common Stock · traded 31 March 2022 · filed 1 April 2022
- exercised options over 189 shares of Veeva Systems (a derivative holding)SEC Form 43 March 2022Restricted Stock Units · traded 1 March 2022 · filed 3 March 2022
- exercised options over 189 shares of Veeva SystemsSEC Form 43 March 2022Class A Common Stock · traded 1 March 2022 · filed 3 March 2022
- exercised options over 189 shares of Veeva Systems (a derivative holding)SEC Form 43 December 2021Restricted Stock Units · traded 1 December 2021 · filed 3 December 2021
- exercised options over 189 shares of Veeva SystemsSEC Form 43 December 2021Class A Common Stock · traded 1 December 2021 · filed 3 December 2021
- exercised options over 189 shares of Veeva Systems (a derivative holding)SEC Form 43 September 2021Restricted Stock Units · traded 1 September 2021 · filed 3 September 2021
- exercised options over 189 shares of Veeva SystemsSEC Form 43 September 2021Class A Common Stock · traded 1 September 2021 · filed 3 September 2021
- ▲ bought on the open market 12,500 shares of BiomXSEC Form 430 July 2021Common Stock · traded 28 July 2021 · filed 30 July 2021
- ▲ bought on the open market 9,375 shares of BiomX (a derivative holding)SEC Form 430 July 2021Common Stock Warrant · traded 28 July 2021 · filed 30 July 2021
- exercised options over 216 shares of Veeva SystemsSEC Form 425 June 2021Class A Common Stock · traded 25 June 2021 · filed 25 June 2021
- exercised options over 216 shares of Veeva Systems (a derivative holding)SEC Form 425 June 2021Restricted Stock Units · traded 25 June 2021 · filed 25 June 2021
- was granted 756 shares of Veeva Systems (a derivative holding)SEC Form 424 June 2021Restricted Stock Units · traded 23 June 2021 · filed 24 June 2021
- exercised options over 20,000 shares of Veeva SystemsSEC Form 421 June 2021Class A Common Stock · traded 17 June 2021 · filed 21 June 2021
- ▼ sold on the open market 1,839 shares of Veeva SystemsSEC Form 421 June 2021Class A Common Stock · traded 17 June 2021 · filed 21 June 2021
- exercised options over 20,000 shares of Veeva Systems (a derivative holding)SEC Form 421 June 2021Stock Option (right to buy) · traded 17 June 2021 · filed 21 June 2021
- was granted 15,200 shares of BiomX (a derivative holding)SEC Form 41 April 2021Common Stock Options - Right to Buy · traded 30 March 2021 · filed 1 April 2021
- exercised options over 217 shares of Veeva Systems (a derivative holding)SEC Form 426 March 2021Restricted Stock Units · traded 25 March 2021 · filed 26 March 2021
- exercised options over 217 shares of Veeva SystemsSEC Form 426 March 2021Class A Common Stock · traded 25 March 2021 · filed 26 March 2021
- exercised options over 216 shares of Veeva Systems (a derivative holding)SEC Form 428 December 2020Restricted Stock Units · traded 25 December 2020 · filed 28 December 2020
- gave away 200 shares of Veeva SystemsSEC Form 428 December 2020Class A Common Stock · traded 22 December 2020 · filed 28 December 2020
- exercised options over 216 shares of Veeva SystemsSEC Form 428 December 2020Class A Common Stock · traded 25 December 2020 · filed 28 December 2020
- was granted 16,000 shares of BiomX (a derivative holding)SEC Form 45 October 2020Common Stock Options - Right to Buy · traded 2 October 2020 · filed 5 October 2020
- exercised options over 217 shares of Veeva Systems (a derivative holding)SEC Form 428 September 2020Restricted Stock Units · traded 25 September 2020 · filed 28 September 2020
- exercised options over 217 shares of Veeva SystemsSEC Form 428 September 2020Class A Common Stock · traded 25 September 2020 · filed 28 September 2020
- was granted 866 shares of Veeva Systems (a derivative holding)SEC Form 426 June 2020Restricted Stock Units · traded 25 June 2020 · filed 26 June 2020
- exercised options over 299 shares of Veeva Systems (a derivative holding)SEC Form 422 June 2020Restricted Stock Units · traded 20 June 2020 · filed 22 June 2020
- exercised options over 299 shares of Veeva SystemsSEC Form 422 June 2020Class A Common Stock · traded 20 June 2020 · filed 22 June 2020
- gave away 375 shares of Veeva SystemsSEC Form 45 June 2020Class A Common Stock · traded 4 June 2020 · filed 5 June 2020
- ▼ sold on the open market 1,854 shares of Veeva SystemsSEC Form 430 March 2020Class A Common Stock · traded 27 March 2020 · filed 30 March 2020
- exercised options over 299 shares of Veeva Systems (a derivative holding)SEC Form 423 March 2020Restricted Stock Units · traded 20 March 2020 · filed 23 March 2020
- exercised options over 299 shares of Veeva SystemsSEC Form 423 March 2020Class A Common Stock · traded 20 March 2020 · filed 23 March 2020
- was granted 7,650 shares of Alpine Immune Sciences (a derivative holding)SEC Form 46 January 2020Stock Option (Right to buy) · traded 2 January 2020 · filed 6 January 2020
- exercised options over 300 shares of Veeva Systems (a derivative holding)SEC Form 420 December 2019Restricted Stock Units · traded 20 December 2019 · filed 20 December 2019
- exercised options over 300 shares of Veeva SystemsSEC Form 420 December 2019Class A Common Stock · traded 20 December 2019 · filed 20 December 2019
- ▼ sold on the open market 4,615 shares of Veeva SystemsSEC Form 49 December 2019Class A Common Stock · traded 6 December 2019 · filed 9 December 2019
- ▼ sold on the open market 628 shares of Veeva SystemsSEC Form 48 October 2019Class A Common Stock · traded 4 October 2019 · filed 8 October 2019
- exercised options over 299 shares of Veeva Systems (a derivative holding)SEC Form 423 September 2019Restricted Stock Units · traded 20 September 2019 · filed 23 September 2019
- exercised options over 299 shares of Veeva SystemsSEC Form 423 September 2019Class A Common Stock · traded 20 September 2019 · filed 23 September 2019
- ▼ sold on the open market 601 shares of Veeva SystemsSEC Form 425 June 2019Class A Common Stock · traded 24 June 2019 · filed 25 June 2019
- was granted 1,197 shares of Veeva Systems (a derivative holding)SEC Form 421 June 2019Restricted Stock Units · traded 20 June 2019 · filed 21 June 2019
- exercised options over 627 shares of Veeva Systems (a derivative holding)SEC Form 417 June 2019Restricted Stock Units · traded 13 June 2019 · filed 17 June 2019
- exercised options over 627 shares of Veeva SystemsSEC Form 417 June 2019Class A Common Stock · traded 13 June 2019 · filed 17 June 2019
- ▼ sold on the open market 600 shares of Veeva SystemsSEC Form 425 March 2019Class A Common Stock · traded 22 March 2019 · filed 25 March 2019
- exercised options over 628 shares of Veeva Systems (a derivative holding)SEC Form 415 March 2019Restricted Stock Units · traded 13 March 2019 · filed 15 March 2019
- exercised options over 628 shares of Veeva SystemsSEC Form 415 March 2019Class A Common Stock · traded 13 March 2019 · filed 15 March 2019
- was granted 7,650 shares of Alpine Immune Sciences (a derivative holding)SEC Form 44 January 2019Stock Option (Right to buy) · traded 2 January 2019 · filed 4 January 2019
- ▼ sold on the open market 601 shares of Veeva SystemsSEC Form 427 December 2018Class A Common Stock · traded 26 December 2018 · filed 27 December 2018
- ▼ sold on the open market 7,804 shares of Veeva SystemsSEC Form 420 December 2018Class A Common Stock · traded 18 December 2018 · filed 20 December 2018
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.